卵巢交界性透明细胞肿瘤1例
摘要
<正>患者女性,43岁,入院10 h前无明显诱因下腹部胀痛,持续性加重,伴潮热、头晕、头痛,妇科检查双侧附件轻压痛,以左侧附件区明显,无反跳痛。B超示:子宫前位,大小、形态正常,内膜厚约9 mm。左侧附件见一囊性包块,大小41mm×38 mm×35 mm,边界清,壁薄,内透声好,内见多个稍强回声光带。右侧附件区未见明显异常包块。病理检查眼观:送检腹腔镜手术切除囊壁样组织2块,其中一块组织颜色灰白,大小6. 5 cm×5. 3 cm,囊壁厚
引文
[1] Pasaoˇglu O,Cift9i E,Tel N,et al. Benign clear cell adenofibroma of the ovary. A case report with literature review[J]. Gynecol Obstet Invest,2007,64(1):36-39.
[2] Cakir E,Aydin E,Durmus N I,et al. Primary ovarian clear cell adenofibroma of borderline malignancy[J]. Oman Med J,2012,27(1):e031.
[3] Hauptmann S,Friedrich K,Redline R,et al. Ovarian borderline tumors in the 2014 WHO classification:evolving concepts and diagnostic criteria[J]. Virchows Arch,2017,470(2):125-142.
[4]高光,孙萍丽,张小辉,等.卵巢子宫内膜异位症合并卵巢交界性透明细胞肿瘤1例[J].临床与实验病理学杂志,2009,25(4):448-450.
[5] Yamamoto S,Tsuda H,Takano M,et al. Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary:a possible alternative ovarian clear-cell carcinogenic pathway[J]. J Pathol,2008,216(1):103-110.
[6] Liu J L,Chu P Y,Yeh K T,et al. Borderline clear cell adenofibroma with extensive hemorrhagic necrosis[J]. Hematol Oncol Stem Cell Ther,2010,3(3):158-160.
[7] Zhao C,Wu L S,Barner R. Pathogenesis of ovarian clear cell adenofibroma,atypical proliferative(borderline)tumor,and carcinoma:clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development[J]. J Cancer,2011,21(2):94-106.
[8] Kleebkaow P,Aue-Aungkul A,Temtanakitpaisan A,Kietpeerakool C. Borderline clear cell adenofibroma of the ovary[J]. Case Rep Pathol, 2017, 2017:3860107. doi:10. 1155/2017/3860107.
[9] Uzan C,Dufeu-Lefebvre M,Fauvet R,et al. Management and prognosis of clear cell borderline ovarian tumor[J]. Int J Gynecol Cancer,2012,22(6):993-999.
[2] Cakir E,Aydin E,Durmus N I,et al. Primary ovarian clear cell adenofibroma of borderline malignancy[J]. Oman Med J,2012,27(1):e031.
[3] Hauptmann S,Friedrich K,Redline R,et al. Ovarian borderline tumors in the 2014 WHO classification:evolving concepts and diagnostic criteria[J]. Virchows Arch,2017,470(2):125-142.
[4]高光,孙萍丽,张小辉,等.卵巢子宫内膜异位症合并卵巢交界性透明细胞肿瘤1例[J].临床与实验病理学杂志,2009,25(4):448-450.
[5] Yamamoto S,Tsuda H,Takano M,et al. Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary:a possible alternative ovarian clear-cell carcinogenic pathway[J]. J Pathol,2008,216(1):103-110.
[6] Liu J L,Chu P Y,Yeh K T,et al. Borderline clear cell adenofibroma with extensive hemorrhagic necrosis[J]. Hematol Oncol Stem Cell Ther,2010,3(3):158-160.
[7] Zhao C,Wu L S,Barner R. Pathogenesis of ovarian clear cell adenofibroma,atypical proliferative(borderline)tumor,and carcinoma:clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development[J]. J Cancer,2011,21(2):94-106.
[8] Kleebkaow P,Aue-Aungkul A,Temtanakitpaisan A,Kietpeerakool C. Borderline clear cell adenofibroma of the ovary[J]. Case Rep Pathol, 2017, 2017:3860107. doi:10. 1155/2017/3860107.
[9] Uzan C,Dufeu-Lefebvre M,Fauvet R,et al. Management and prognosis of clear cell borderline ovarian tumor[J]. Int J Gynecol Cancer,2012,22(6):993-999.